Colombia University Trial: Scan Diet Significantly More Effective Than Trying To Lose Weight On One’s Own With The ADA Recommended Diet
February 2003 - In the upcoming issue of the European Journal of Clinical Nutrition (March 2003) a landmark clinical study has found Scan Diet to be more effective at helping people achieve weight loss than....
Amersham, Bucks, February 2003
In the upcoming issue of the European Journal of Clinical Nutrition (March 2003) a landmark clinical study has found Scan Diet to be more effective at helping people achieve weight loss than simply recommending a diet of similar caloric value based on American Dietetic Association dietary guidelines. This study, sponsored by Nutri Pharma, was performed at the New York Obesity Research Center at St. Luke’s Roosevelt Hospital and Columbia University.
Dr David Allison, who designed, oversaw and analysed the study, comments:
“We studied 100 overweight and obese Americans in this clinical trial and people lost substantial weight – an average of 15.4 lbs – after 12 weeks on the Scan Diet regime versus an average weight loss of just 6.37 lbs in the control group. Not only did those on Scan Diet have significantly greater weight loss, they also benefited from significantly more reduced total and LDL cholesterol levels than the control group.”
These are significant findings at a time when cardiovascular disease – widely documented as a result of health conditions such as obesity – contributes to almost half of all deaths in industrialised countries in the world today.
Scan Diet, developed by Nutri Pharma, harnesses the health benefits of soy and is the result of 20 years dedicated research into the field of soy technology by Nutri Pharma founder Dr Lars Hoie. His findings were used as the basis for developing Nutri Pharma’s patented soy composition, which is an integral component of Scan Diet.
Scan Diet is the only patented soy based weight reduction product, where the patented soy components are responsible for the significant reduction of total and LDL cholesterol.
Dr Hoie comments:
“As the incidence of obesity continues to drastically increase there is a demand for the evaluation of treatment options outside
the traditional medical arena. Of course weight loss can be achieved through a sensible diet however, limiting calorie intake
often does little to lower cholesterol levels and ensure healthy weight loss. Scan Diet provides a simple and sensible way
to manage daily calorie intake ensuring effective and safe weight loss in the long run.”
Scan Diet is available in the US through GNC stores nationwide and the product range includes bars and shakes. Prices start at $1.99.
For more details of Scan Diet visit www.scandiet.com
For further information on this trial or Nutri Pharma please contact:
Nicky Parnell Tel 020 7072 4100 nparnell@gciuk.com
Sarah Beck Tel 020 7072 4100 sbeck@gciuk.com
NOTES TO EDITORS
Colombia University, New York Trial
The Columbia University, New York Trial, sponsored by Nutri Pharma, was conducted by scientists from The New York Obesity
Research Centre at St Luke’s/ Roosevelt Hospital
The trial recruited 100 overweight and obese American patients.
The trial observed changes in weight, body fat and lipid concentrations of those participants receiving Scan Diet over a three-month
period compared to the control group.
Both experimental and control groups followed a 1,200 kcal/ day diet with dietary counselling sessions and educational materials
provided.
The control diet was prescribed from the American Dietetic Association exchange lists.
Those receiving Scan Diet were found to have significantly reduced:
weight (15.4lbs compared to 6.37lbs in the control group)
fat mass (9.46lbs compared to 3.1lbs)
waist circumference (6.0 cm compared to 2.9 cm in the control group)
total cholesterol (22.5 mg/ dL compared to 6.8 mg/ dL)
LDL cholesterol levels (21.2 mg/dL compared to 7.1 mg/ dL in the control group)
Patients from the Columbia University, New York Trial have been monitored for one year and the progress of weight loss could
be documented.

